Sigilon TherapeuticsInc Performance
| SGTXDelisted Stock | USD 22.47 0.00 0.00% |
The entity has a beta of -6.07, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Sigilon TherapeuticsInc are expected to decrease by larger amounts. On the other hand, during market turmoil, Sigilon TherapeuticsInc is expected to outperform it. Sigilon TherapeuticsInc right now has a risk of 0.0%. Please validate Sigilon TherapeuticsInc downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall , to decide if Sigilon TherapeuticsInc will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sigilon TherapeuticsInc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Sigilon TherapeuticsInc is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 108.5 M |
Sigilon |
Sigilon TherapeuticsInc Relative Risk vs. Return Landscape
If you would invest 2,247 in Sigilon TherapeuticsInc on January 25, 2024 and sell it today you would earn a total of 0.00 from holding Sigilon TherapeuticsInc or generate 0.0% return on investment over 90 days. Sigilon TherapeuticsInc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Sigilon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sigilon TherapeuticsInc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sigilon TherapeuticsInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sigilon TherapeuticsInc, and traders can use it to determine the average amount a Sigilon TherapeuticsInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SGTX |
Based on monthly moving average Sigilon TherapeuticsInc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sigilon TherapeuticsInc by adding Sigilon TherapeuticsInc to a well-diversified portfolio.
Sigilon TherapeuticsInc Fundamentals Growth
Sigilon Stock prices reflect investors' perceptions of the future prospects and financial health of Sigilon TherapeuticsInc, and Sigilon TherapeuticsInc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sigilon Stock performance.
| Return On Equity | -0.76 | |||
| Return On Asset | -0.24 | |||
| Profit Margin | (1.71) % | |||
| Operating Margin | (1.75) % | |||
| Current Valuation | 28.99 M | |||
| Shares Outstanding | 2.5 M | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.87 X | |||
| Revenue | 12.94 M | |||
| EBITDA | (41.27 M) | |||
| Cash And Equivalents | 88.21 M | |||
| Cash Per Share | 2.72 X | |||
| Total Debt | 28.06 M | |||
| Debt To Equity | 0.61 % | |||
| Book Value Per Share | 10.97 X | |||
| Cash Flow From Operations | (51.47 M) | |||
| Earnings Per Share | (14.83) X | |||
| Total Asset | 87.28 M | |||
| Retained Earnings | (256.8 M) | |||
About Sigilon TherapeuticsInc Performance
To evaluate Sigilon TherapeuticsInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Sigilon TherapeuticsInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Sigilon Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Sigilon TherapeuticsInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Sigilon's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Sigilon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 66 people.Things to note about Sigilon TherapeuticsInc performance evaluation
Checking the ongoing alerts about Sigilon TherapeuticsInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sigilon TherapeuticsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sigilon TherapeuticsInc is not yet fully synchronised with the market data | |
| Sigilon TherapeuticsInc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.94 M. Net Loss for the year was (43.56 M) with loss before overhead, payroll, taxes, and interest of (24.69 M). | |
| Sigilon TherapeuticsInc currently holds about 88.21 M in cash with (51.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72. |
- Analyzing Sigilon TherapeuticsInc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sigilon TherapeuticsInc's stock is overvalued or undervalued compared to its peers.
- Examining Sigilon TherapeuticsInc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sigilon TherapeuticsInc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sigilon TherapeuticsInc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sigilon TherapeuticsInc's stock. These opinions can provide insight into Sigilon TherapeuticsInc's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon TherapeuticsInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon TherapeuticsInc's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |